Citadel Advisors’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Citadel Advisors's CTV.WS Position: Q1 2025 in Review

Citadel Advisors sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2025, closing a stake of 10,155 shares — an estimated $1.12K sold.

Citadel Advisors first reported a position in CTV.WS in Q4 2024 and held it in 1 quarter. The position peaked at $1.12K in Q4 2024. 1 fund tracked by Wall St. Rank holds CTV.WS as of Q1 2025.

• Citadel Advisors reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2025 after selling out during the quarter.
• Citadel Advisors sold 10,155 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2025, an estimated $1.12K.
• Citadel Advisors first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2024 and held it in 1 quarter.
• Citadel Advisors's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $1.12K in Q4 2024.
• 1 fund tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.